Quintiles focuses on cancer biomarkers

Quintiles VP of strategic business and oncology operations, Christopher Ung, sat down with Outsourcing-pharma recently to review the importance of biomarkers in cancer drug development. Fewer than one in 10 NMEs in the oncology realm actually reach the market while six out of 10 late-stage cancer drug trials fail. Report

Suggested Articles

Takeda tapped Roche’s Foundation Medicine to develop tissue- and blood-based companion diagnostic tests for its portfolio of lung cancer therapies.

Cellex has announced plans to develop a rapid coronavirus test that people can fully perform at home, from sample collection to result, using an app.

More than 20 states either don’t release or have incomplete data on the rapid antigen tests now considered key to containing the coronavirus.